Explicyte is a preclinical and translational contract research organization specialized in immuno-oncology. Our goal is to assist academics, biotechs, and pharmas in the discovery of novel targets and novel cancer immunotherapies.
With a team of 25, we’re a human-sized company, which brings under the same roof cell biologists, immunologists, in vivo scientists, medical oncologists, and bioinformaticians. Focused on sponsors’ projects, our activity also involves in-house R&D and external collaborations, which led to the publication of 25+ papers in high-impact-factor journals.
Based in Bordeaux, our lab is located at the Bergonié Comprehensive Cancer Center, where we work in close contact with medical oncology teams. We believe Explicyte is a place to learn, grow, and have impact in the fight against cancer.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 229 Cours De L'argonne, Bordeaux,nouvelle-Aquitaine 33000,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.explicyte.com
- Keywords
- Preclinical research services, CRO, In vitro and In vivo, Service provider, Oncology, Immuno-Oncology.
- HQ
- Bordeaux, Nouvelle-Aquitaine
Explicyte Questions
Explicyte's website is http://www.explicyte.com
Explicyte's LinkedIn profile is https://fr.linkedin.com/company/explicyte
Explicyte has
10 employees.
View email and phone details for 10
employees at Explicyte.
Explicyte's industry is
Biotechnology Research
Explicyte's top competitors are
Immusmol,
Immunext,
Cellectis,
Neoearth,
Aelis Farma,
Treefrog Therapeutics,
Fluofarma,
Majus Therapeutics,
Novaptech,
Cure51.
Explicyte's categories are Biotechnology Research
Explicyte's founding year is 2015
